Loading…
XBiotech Inc. is projected to rise to $2.80 by 2027, a +22% move from its current price of $2.29. XBIT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.26 | $2.29 | $2.33 | +0.08% |
| Jul 14 | $2.24 | $2.29 | $2.35 | +0.16% |
| Jul 15 | $2.23 | $2.30 | $2.36 | +0.24% |
| Jul 16 | $2.23 | $2.30 | $2.37 | +0.32% |
| Jul 17 | $2.22 | $2.30 | $2.38 | +0.40% |
| Jul 18 | $2.21 | $2.30 | $2.39 | +0.48% |
| Jul 19 | $2.21 | $2.30 | $2.40 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.21 | $2.30 | $2.40 | +0.56% |
| Week 2 | $2.18 | $2.32 | $2.46 | +1.13% |
| Week 3 | $2.17 | $2.33 | $2.50 | +1.70% |
| Week 4 | $2.15 | $2.34 | $2.55 | +2.27% |
| Week 5 | $2.14 | $2.36 | $2.59 | +2.85% |
| Week 6 | $2.14 | $2.37 | $2.62 | +3.43% |
| Week 7 | $2.13 | $2.38 | $2.66 | +4.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
XBiotech is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating various diseases. Its pipeline targets inflammatory and infectious diseases, and it is developing interleukin-1 alpha therapies for medical conditions such as cancer, stroke, heart attack, or arthritis; these therapies relate to tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBiotech (XBIT) is currently trading at $2.31 per share, with a market capitalization of $70.43M. The stock holds a place in the market with a rank of 5440. The price outlook reflects a bullish path beyond 2026, with the forecast showing rising averages and ROIs over time.
From 2026 onward, the forecast outlines changing price dynamics, beginning with a 2026 average of $2.31 and a 0 ROI, then moving higher in subsequent years. By 2030 the forecast shows an average of $3.30 with a 43 ROI, and by 2050 an average of $13.22 with a 472.4 ROI, signaling a long-run bullish trajectory.
A major floor 4.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 6.6% above — a clean break opens room to run.
A major ceiling 12.4% above — clearing it would confirm fresh momentum.
Key XBIT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XBIT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.35 | Sell | $2.32 | Sell |
| MA 10 | $2.33 | Sell | $2.33 | Sell |
| MA 20 | $2.33 | Sell | $2.34 | Sell |
| MA 50 | $2.40 | Sell | $2.37 | Sell |
| MA 100 | $2.39 | Sell | $2.41 | Sell |
| MA 200 | $2.44 | Sell | $2.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.30 | Neutral |
| Stoch RSI (14) | 17.95 | Buy |
| CCI (20) | -118.06 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.72 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 46.12 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 2.33 | Sell |
| ADX (14) | 17.50 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearish with a current sentiment labeled as BEARISH. The RSI(14) sits at 40, indicating modest downside pressure relative to overbought/oversold thresholds.
The 50-day simple moving average is $2.44 and the 200-day simple moving average is $2.47, suggesting near-term resistance around the mid-$2 range. Support is identified at $2.31 and resistance at $2.50, framing a narrow trading band.
The 30-day range spans from $2.07 to $2.58, and the stock exhibits annualized volatility of 30%, reflecting notable but contained price fluctuations in the month ahead.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.25 | $2.29 | $3.22 | 0% | Neutral | |
| $2.30 | $2.80 | $3.58 | +22% | Bullish | |
| $2.43 | $3.02 | $3.96 | +32% | Bullish | |
| $2.63 | $3.32 | $4.45 | +45% | Bullish | |
| $2.56 | $3.28 | $4.47 | +43% | Bullish | |
| $2.75 | $3.56 | $4.93 | +55% | Bullish | |
| $3.07 | $4.02 | $5.65 | +76% | Bullish | |
| $3.44 | $4.56 | $6.48 | +99% | Bullish | |
| $3.96 | $5.30 | $7.63 | +131% | Bullish | |
| $3.94 | $5.32 | $7.75 | +132% | Bullish | |
| $5.58 | $7.86 | $11.99 | +243% | Bullish | |
| $9.20 | $13.90 | $22.72 | +507% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.25 | $2.29 | $2.79 | +0.00% |
| August 2026 | $2.09 | $2.45 | $2.93 | +7.03% |
| September 2026 | $2.09 | $2.46 | $2.97 | +0.52% |
| October 2026 | $2.13 | $2.52 | $3.05 | +2.13% |
| November 2026 | $2.21 | $2.61 | $3.19 | +3.85% |
| December 2026 | $2.21 | $2.62 | $3.22 | +0.38% |
Click any year to see its month-by-month XBIT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, XBIT is projected to trade between $2.25 and $3.22, averaging $2.29 — a potential gain of 0% from today's $2.29. Price action looks broadly range-bound.
XBiotech Inc.'s 2027 outlook centres on $2.80, within a $2.30 to $3.58 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, XBIT could reach as high as $3.96, with a base case around $3.02 and support toward $2.43 — roughly +32% from $2.29. Momentum favours further upside here.
Expect XBIT to range from $2.63 to $4.45 through 2029. The $3.32 average target implies a +45% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The XBIT price prediction for 2030 points to an average of $3.28 (low $2.56, high $4.47) — a potential gain of +43% on today's $2.29. Momentum favours further upside here.
In 2031, XBIT is projected to trade between $2.75 and $4.93, averaging $3.56 — a potential gain of +55% from today's $2.29. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
XBiotech Inc.'s 2032 outlook centres on $4.02, within a $3.07 to $5.65 range. That is up +13% on the projected 2031 average. That marks a +76% change versus current levels. Momentum favours further upside here.
By 2033, XBIT could reach as high as $6.48, with a base case around $4.56 and support toward $3.44 — roughly +99% from $2.29. Buyers look set to stay in control over this stretch.
Expect XBIT to range from $3.96 to $7.63 through 2034. The $5.30 average target implies a +131% move from current prices. That is up +16% on the projected 2033 average. Momentum favours further upside here.
The XBIT price prediction for 2035 points to an average of $5.32 (low $3.94, high $7.75) — a potential gain of +132% on today's $2.29. Buyers look set to stay in control over this stretch.
In 2040, XBIT is projected to trade between $5.58 and $11.99, averaging $7.86 — a potential gain of +243% from today's $2.29. That is up +48% on the projected 2035 average. Momentum favours further upside here.
XBiotech Inc.'s 2050 outlook centres on $13.90, within a $9.20 to $22.72 range. That is up +77% on the projected 2040 average. That marks a +507% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in XBIT today (≈ 436.681223 XBIT) could be worth
$6,067.85
+$5,067.85 (+507%) by 2050 · US Dollar
Based on the average projected XBIT price of $13.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XBITwould be worth at today's price.
$1,000 invested in XBIT on Jul 10, 2025 (≈ 337.837833 XBIT) would be worth
$773.65
-$226.35 (-22.6%) today · 0.77× · US Dollar
Based on a XBIT entry price of $2.96 vs. today's $2.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.3 | $995.65 | -0.4% |
| 1 month ago | $2.35 | $974.47 | -2.6% |
| 3 months ago | $2.33 | $982.83 | -1.7% |
| 6 months ago | $2.53 | $905.14 | -9.5% |
| 1 year ago | $2.96 | $773.65 | -22.6% |
| All time (5.0y) ago | $18.24 | $125.55 | -87.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XBIT forecast.
Our base-case forecast reaches $4.60 around 2034.
Implied market cap at $4.60: $140.24M
The multi-year forecast paints a bullish trajectory with progressively higher averages and ROIs through 2030, 2040, and 2050. In 2026, the average price is $2.31 with an ROI of 0 and a Neutral sentiment. By 2030, the average climbs to $3.30 with an ROI of 43 and a bullish tone, while 2040 shows an average of $7.78 with an ROI of 236.9 and continued bullish sentiment.
By 2050 the forecasted average is $13.22 with an ROI of 472.4, maintaining a bullish outlook.
Additional milestones include 2027 avg $2.85 (ROI 23.5), 2028 avg $3.05 (ROI 32.2), 2029 avg $3.28 (ROI 42.2), 2031 avg $3.53 (ROI 53), 2032 avg $3.97 (ROI 71.8), 2033 avg $4.58 (ROI 98.5), 2034 avg $5.22 (ROI 126.2), and 2035 avg $5.17 (ROI 123.8). These figures illustrate a steady, long-run expansion path, though as always these are estimates, not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast gives an average price of $3.30 in 2030 with a min of $2.58 and a max of $4.51, and an ROI of 43. The sentiment is bullish.
The forecast shows a Neutral stance in 2026 and a Bullish path from 2027 onward, with rising averages (e.g., $2.85 in 2027, $3.30 in 2030) and higher ROIs (up to 43 in 2030 and 472.4 by 2050). These are estimates, not guarantees.
Yes. The forecast projects higher price levels, with 2032 max at $5.58 and 2033 max at $6.53, indicating the possibility of surpassing $5 in the later years.
The forecast shows a max of $11.87 in 2040, which means reaching or exceeding $10 is within the projected upside in that horizon.
Current price is $2.31 and market cap is $70.43M. These figures frame the present valuation used for the forward-looking forecasts.
XBiotech Inc. Community Discussion
0Share your XBiotech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.